Organigram Global (OGI) Return on Invested Capital (2019 - 2025)

Organigram Global (OGI) posted quarterly Return on Invested Capital of 0.65% for Q1 2025, up 4597.38% on a QoQ basis from 0.01% in Q3 2020.

Organigram Global (OGI) Return on Invested Capital (2019 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Return on Invested Capital for 3 consecutive years, with 0.65% the latest figure, recorded in Q1 2025.

Quarterly Return on Invested Capital changed N/A year-over-year to 0.65% in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.65% (changed N/A YoY) and the FY2020 annual result came in at 0.02%, down 2.0% from the prior year.
Return on Invested Capital climbed to 0.65% in Q1 2025 per OGI's latest filing, from 0.01% in the prior quarter.
Over the last five years, Return on Invested Capital for OGI reached as high as 0.65% in Q1 2025 and fell as low as 0.65% in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	0.01%
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	0.01%
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	0.00%
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	0.00%
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	0.03%
10	Organigram Global	89.89 Mn	122.96 Mn	28.97 Mn	-

Download Data